If I’d been told that six years after having invested in CYDY the SP would be .60 I would have thought the science failed miserably. The ridiculous fact is the science is off the charts with no safety issues and yet no partner or non dilutive financing options. Pestell is a done deal with all the upside that he brings to the table and here we sit at .60. 2019 has to be our year. How can the market ignore the very high likelihood of this science disrupting both the HIV and TNBC space? Logic says it cannot.
The remaining question to be answered is what will be the catalyst that breaks the damn wide open. My gut tells me once we get some real backing from a partner or an IB and clean up the balance sheet we will never look back. With the Pestell deal closed we may be fast approaching this scenario. Can’t wait for that day and we see predominantly GREEN day in day out as we push towards the end game.
Market Data 
Markets 
